Brown, Lisle/Cummings, Inc. Merck & Co., Inc. Transaction History
Brown, Lisle/Cummings, Inc.
- $294 Billion
- Q1 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 28,863 shares of MRK stock, worth $3.63 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
28,863
Previous 28,888
0.09%
Holding current value
$3.63 Million
Previous $3.15 Billion
20.93%
% of portfolio
1.29%
Previous 1.17%
Shares
10 transactions
Others Institutions Holding MRK
# of Institutions
3,768Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.1 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.1 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...